A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Phase of Trial: Phase II
Latest Information Update: 04 Dec 2017
At a glance
- Drugs Asimadoline (Primary)
- Indications Pruritus
- Focus Proof of concept; Therapeutic Use
- Sponsors Tioga Pharmaceuticals
- 04 Dec 2017 Results presented in a Tioga Pharmaceuticals media release.
- 04 Dec 2017 Status changed from recruiting to completed according to a Tioga Pharmaceuticals media release.
- 16 Mar 2016 Planned End Date changed from 1 Jun 2016 to 1 Jun 2017 as reported by Clinicaltrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History